Stay updated with breaking news from Remunity Pump. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Axiom Investors LLC DE lessened its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 23.4% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,423 shares of the biotechnology company’s stock after selling 1,043 shares during the period. Axiom Investors LLC DE’s holdings […]
Aviva PLC boosted its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 677.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 91,015 shares of the biotechnology company’s stock after purchasing an additional 79,312 shares during the quarter. Aviva […]
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) has been given an average recommendation of “Moderate Buy” by the ten ratings firms that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating and eight have issued a buy rating on the company. The average 1-year […]
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. acquired a new position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 16,010 shares of the biotechnology company’s stock, valued at approximately $3,586,000. Several other hedge funds […]
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 6,000 shares of the stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $236.25, for a total transaction of $1,417,500.00. Following the completion of the sale, the executive vice president now directly owns 36,599 […]